Search results
Results from the WOW.Com Content Network
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. [3] The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Fresenius Helios is the largest hospital operator and provider of inpatient and outpatient in Germany. The Helios Kliniken has more than 110 hospitals and more than 30,000 beds, treating over 4 million patients annually. Fresenius Kabi is a supplier of essential drugs, clinical nutrition products, and medical devices.
Sturm served as Chief Financial Officer (CFO) of Fresenius since January 2005, and succeeded Ulf Mark Schneider as CEO, who had been in the role from May 2003 to June 2016. [ 3 ] [ 4 ] Sturm initiated the purchase of the Spanish hospital operator Quirónsalud , the largest acquisition in the history of the company, [ 5 ]
Schneider joined Fresenius in November 2001, when he was appointed chief financial officer of Fresenius Medical Care. From May 2003 until June 2016 he was CEO of the parent company Fresenius. Under Schneider's leadership of Fresenius, the number of employees more than tripled, revenue quadrupled and net income increased twelvefold. [4]
RCG was acquired by Fresenius Medical Care (NYSC: FMS) in 2005 for approximately $4.0 billion. [14] Jacobson serves on the board of several health care-oriented companies, and he has served on the board of three New York Stock Exchange companies, including Merck (NYSE: MRK), [15] Renal Care Group (NYSE: RCG), and Kinetic Concepts (NYSE: KCI). [16]
Brandt started his professional career at PriceWaterhouse in Stuttgart, where he was employed from 1981 to 1992. He then served as a member of the executive board of Baxter Deutschland GmbH for seven years before becoming CFO and labor director of Fresenius Medical Care AG, where he served for two years.
The Foundation grants or supports various scientific prizes, including the Else Kröner-Fresenius Immunology Award and the Else Kröner Memorial Award of the German Interdisciplinary Association for Intensive and Emergency Medicine. [5] [6] Winner of the first-ever Else Kröner-Fresenius Award in Immunology was Ruslan Medzhitov, in 2013.
Etienne Jornod held other directorships, including President of Vifor Pharma AG and Vifor Fresenius Medical Care Renal Pharma AG. [6] From 2012 to 2017 he was a member of the Board of Directors of Vaudoise Insurance Group. [7] From 2008 to 2009 he was a member of the board of Publigroupe. He was also a directorial member of Alliance Boots. [4]